ResMed beats quarterly profit estimates on demand for sleep disorder devices
ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder. ResMed makes continuous positive ...
pharmaphorum1d
Lilly preps for rollout of its connected diabetes system
After years of preparation, Eli Lilly is on the ... and can link with compatible devices. That includes continuous glucose monitoring systems developed by Lilly's partner Dexcom as well as other ...
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.
pharmaphorum6d
Lilly doubles down on Dexcom tech for connected insulin devices
Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...